Please ensure Javascript is enabled for purposes of website accessibility

International Flavors & Fragrances Inc (IFF) Q2 2019 Earnings Call Transcript

By Motley Fool Transcribers – Aug 6, 2019 at 7:23PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

IFF earnings call for the period ending June 30, 2019.

Logo of jester cap with thought bubble.

Image source: The Motley Fool.

International Flavors & Fragrances Inc (IFF -2.37%)
Q2 2019 Earnings Call
Aug 6, 2019, 10:00 a.m. ET


  • Prepared Remarks
  • Questions and Answers
  • Call Participants

Prepared Remarks:


At this time, I would like to welcome everyone to the IFF Second Quarter 2019 Earnings Conference Call. [Operator Instructions] Thank you. I would now like to introduce Michael DeVeau, Head of Investor Relations. You may begin.

Michael DeVeau -- Head of Investor Relations and Communications

Thank you. Good morning, good afternoon and good evening everyone. Welcome to IFF's Second Quarter 2019 Conference Call. Yesterday evening, we distributed a press release announcing our financial results, a copy of the release can be found on our IR website at Please note that this call is being recorded live and will be available for replay. Please take a moment to review our forward-looking statements. During the call, we will be making forward-looking statements about the company's performance, particularly with regard to the outlook for our third quarter, second half and full year 2019. These statements are based on how we see things today and contain elements of uncertainty. For additional information concerning the factors that can cause actual results to differ materially from forward-looking statements, please refer to our cautionary statement and risk factors contained in our 10-K filed on February 26, 2019, and our press release, all of which are available on our website.

Today's presentation will include non-GAAP financial measures, which exclude those items that we believe affect comparability. A reconciliation of these non-GAAP financial measures to their respective GAAP measures is set forth in our press release that we issued yesterday and is on our website. With me on the call today is our Chairman and CEO, Andreas Fibig; and our Executive Vice President and CFO, Rich O'Leary. We will start with prepared remarks and then take any questions that you may have. With that, I would now like to introduce Andreas.

Andreas Fibig -- Chairman and Chief Executive Officer

Thank you, Mike. On the call today, I would like to provide a recap of our Vision 2021 which we shared at our Investor Day, the past June. After that, I will provide comments on our second quarter financial results and give an update on our integration progress. Once finished, I will ask Rich to give a more in depth financial review of our business performance and provide an update on our outlook for the balance of the year. Then we will take any questions that you may have.

We are very confident in the long-term outlook for our business. Thanks in large part to our industry-leading innovation, both in diverse customer base and superior product portfolio. IFF has a history of strong sales growth improving profitability. We are excited about the future as we believe the combination of IFF and Frutarom will create significant value for our customers, employees and shareholders.

At our Investor Day in June, we outlined our new Vision 2021 strategy. The Vision 2021 strategy has been designed to leverage our newly combined organization, our enhanced product portfolio, increased natural position, expanded market access, broader customer base and great innovation pipeline, all with our customer at the center of everything we do. Our four strategic pillars include unlocking growth opportunities while we will capitalize on our expanded product portfolio, broader customer base, and extensive geographic presence. We also expect that cross selling and integrated solutions, a relatively new capability set will lead to $100 million sales over the 2019-2021 period, driving innovation while we will invest in high growth and high return platforms to continue to drive our industry-leading R&D pipeline.

I'm pleased to say that with a combination of IFF and Frutarom, our R&D is a strongest it has been in the company's history. We have expanded R&D capabilities with cutting-edge research, all carefully prioritized platforms based on future return potential. Managing the portfolio, while we will focus on optimizing our portfolio to maximize value creation. Our business portfolio is much more broad and diverse with a range of growth potentials and margin profiles. To maximize value creation, we are focusing on disciplined resource allocation while we establish clear guidelines to prioritize our investment decisions as we move forward.

Accelerating business transformation, while we will successfully integrate Frutarom delivering $145 million of synergies, but also continuing our strong productivity agenda in our legacy business for an incremental 100 million in savings. And of course culture, technology, sustainability, M&A and talent all remain critical enablers to our strategy.

From a long-term perspective, we are excited about where we compete. Our market potential is now approximately $50 billion with an estimated 4% total market growth rate. This is a significant increase from just one year ago while estimated market was approximately $26.5 billion with an average growth rate of 2% to 3%. Through Frutarom, we have gained broad exposure in the many attractive adjacencies where growth is approximately 6% in the next five years. This additional access not only provides us with incremental market potential, but we believe growth over the mid and long-term should accelerate as nearly all of these adjacent markets at higher intrinsic growth rates.

To ensure we capture the opportunities ahead, we are realigning our business to take effect in 2020. Frutarom's taste in Savory Solutions will transition and our legacy taste business unit, we are also adding Frutarom's inclusion business, which comprises [Indecipherable] and then different Leagel or ice cream ingredients business into legacy taste. The remaining parts of Frutarom will be grouped into a new nutrition and ingredients division. This high-growth, high-margin business will improve Frutarom's Natural Product Solutions as well as a flavor ingredients business.

At the business unit level, we have focused and prioritized our strategy to ensure we capture future growth potential. Within scent, we serve customers across a wide spectrum of sizes. However, the bulk of all market is composed of multinational companies who work with our core list. We recently won new core list access providing us with the opportunity to compete for $450 million of market potential we previously didn't have access to. This was a significant opportunity for growth and as such we are focused on capitalizing on our new access with maintaining strong improvements with regional and local customers.

Our go-forward goal in scent is to drive value equations through disciplined portfolio management, investing in high-margin businesses and fixing profitability categories that have been disproportionately impacted by higher raw material cost. In addition, we have identified and executed on opportunities to streamline our organization within the scent business unit, which is already contributing approximately $4 million of savings for the first half of 2019.

In Taste, the focus on effectively integrating the Frutarom businesses and our go-to-market approaches by expanding our Tastepoint model to ensure we serve and capture opportunities with faster-growing small and mid-sized customers in other key markets around the world. We are also targeting higher growth geographies. For example, Africa, the Middle East and enhancing our portfolio by expanding Savory Solutions and inclusions globally.

In Nutrition & Ingredients, it's all about geographic expansion, focusing on differentiating natural and clean label technologies and targeting value-enhancing acquisitions. The majority of the categories within the division, natural health ingredients, natural food protection, and Natural Colors, all have strong future growth potential.

And we are focused on increasing our scale to disproportionate growth at accelerated rates. At the core, we anticipate that our baseline currency neutral growth to be approximately 3% to 5%. Then we believe that we have incremental opportunities to long-term to add an additional percentage point for cross selling and integrated solutions, as well as another percentage points for acquisitions. The net result is that we expect overall currency neutral sales growth to average 5% to 7% over the next three years.

Taking a step back, we now have the broadest and deepest portfolio of businesses in our long history, one that provides a variety of investment options. To maximize value creation, we have established portfolio roles and clear guidelines to prioritize our investment decisions. There are three approaches to managing our portfolio. Growth, while we will accelerate margin accretive categories so incremental investments such as Fine Fragrance and Cosmetic Active Ingredients. Balanced, while we will self-fund investments to maintain gross margin and cash flow. And Fix, while we will have limited investments until margin goals achieved targeted levels or we deprioritize. An example of this is Trade & Marketing while we have deprioritized our ports given the margin profile, all the businesses we exited earlier this year.

As you can see, we have categories in all of these three portfolio classifications. These specifications will streamline our category management and fine-tune our strategic efforts to ensure we grow sales and also improve our margins. We have strong programs in place to drive profitability. From 2019 to 2021, we expect margin improvements to be driven, our portfolio optimization strategy in the $145 million of integration savings from the Frutarom transaction.

As discussed, portfolio optimization is expected to improve profit as margin, management, pricing, cost leverage, and selective pooling of our low margin and non-strategic sales will drive overall margin expansion. Within our planned integration synergies from the Frutarom acquisitions, we are rationalizing and harmonizing our procurement activities via leveraged spent and [Indecipherable] We are also optimizing the global footprint, as we expect approximately 35 sites globally to be optimized, which will generate additional efficiencies. The last piece is streamlining of overhead expense, which is intended to reduce non-strategic cost and eliminating redundant expenses. We are highly confident in our ability to achieve $145 million in cost savings target at the end of 2021.

In addition to our integration synergies, we expect approximately $100 million savings in additional productivity programs. Beyond margin expansion, these initiatives are key in a journey to fundamentally transform how we operate, focusing on process improvements simplifications and centralization. This will provide flexibility to drive bottom line results and reinvest in our growth engines.

Our long-term financial objectives are clear. This includes top third total shareholder return, our drivers are 5% to 7% currency-neutral gross, margin expansion to be less than 3 times net debt to EBITDA in 18 to 24 months, 10% plus adjusted EPS growth excluding amortization, and approximately a 2% dividend yield. Our Vision 2021 strategy is focused on disciplined execution and integration. We remain steadfast in our approach and belief in the long-term value equation for all of our stakeholders.

Turning now to the second quarter, year-over-year results on a consolidated basis was strong, including the contribution of Frutarom. Reported sales increased 40%, with the largest driver being the contribution of additional sales related to Frutarom. As communicated at our June Investor Day, currency neutral performance on a combined basis was soft due to a significant volume erosion with multinational customers within Taste and a continued pressure was in Frutarom driven by decline in F&F ingredients notably CitraSource, Natural Colors pricing, parts of Savory Solutions and Trade & Marketing.

By which we'll go into details at the moment, I feel is important to highlight several strong performances within the quarter to ensure we do not lose sight of the progress we are making. In Scent, we have delivered mid single digit sales growth with growth in all categories and double-digit adjusted segment profit growth, both on a currency neutral basis.

Within the rest of the business, several of the high growth categories continue to have solid performances led by beverage and savory and taste, natural food protection, gelato, the ice cream ingredients business, and [Indecipherable] Frutarom. In addition, the businesses we have acquired since of beginning of the year Mighty, Leagel, and [Indecipherable] Canada are all growing at or above our expectations. From a profitability perspective, we are also pleased that adjusted operating profit margin, excluding amortization improved improved 80 bps year-over-year, driven by productivity initiatives and acquisitions related synergies, a market accelerations of our first quarter performance.

I am pleased to report that our integration efforts are well under way, and we are making excellent, excellent progress. For those businesses where we have aligned our go-to-market approach with IFF, growth was strong, increase in high single digits. In terms of cross-selling and integrated solutions, we have already achieved $8 million run rate sales. Longer term, we believe that we can deliver at least $100 million of topline sales by 2021. We are leveraging the compelling combination of R&D technologies and capabilities of both organizations. As stated many times, innovation drives differentiation and is critical for long-term success.

I'm pleased with the progress the team is making and as they strengthens our product offering to our customers. Turning to cost synergies, we've made strong advancements year-to-date as we have achieved approximately $15 million in the first half of 2019. Based on our progress to date and our expectation of savings benefit to accelerate throughout the year, we are now forecasting that we will achieve approximately $40 million in cost savings in 2019, up from our previous estimate of $30 to $35 million. In terms of debt repayment and cash flow, our operating cash flow was up $130 million the first half of 2019 compared to the previous year period and we repaid 47 million in the first half of 2019. With that, I would like to turn the call over to Rich.

Richard O'Leary -- Executive Vice President and Chief Financial Officer

Thank you, Andreas. In the second quarter, we delivered quarterly sales of approximately $1.3 billion on a combined basis, currency neutral for sales grew 1% driven by acquisitions and strong growth in Scent. We also maintained strong profitability levels led by productivity initiatives, acquisition related synergies and favorable price versus input costs. This combined with the additional Frutarom, led to a very strong 29% increase over the prior year period, and adjusted operating profit margin, excluding amortization, improved 80 basis points year-over-year. Our financial results were in line with my comments at our Investor Day when I said we would be between 1% to 3% depending upon how June progressed. And while we did not finish as strong as we would have liked in terms of sales, we did a good job delivering overall profitability in line with our expectations.

From a cash flow perspective, we had significant year-over-year increases in operating cash flow and free cash flow to drive primarily by higher earnings and amortization. As we've done previously, I would like to highlight the impact of emerging market pricing on our growth rates to better compare with our peers. As a reminder for a variety of reasons many of our sales transactions in the emerging markets occur either in U.S. dollars or other hard currencies where our index to hard currencies when we have to invoice in local market currencies.

When reporting our currency-neutral sales growth, we exclude foreign exchange related price changes in emerging markets. But this is different from our peers. We believe our reporting standard provides investors with a truer assessment of underlying currency neutral growth. Especially when there are large emerging market devaluations relative to the U.S. dollar or Euro. However, it's important to help all you understand our performance relative to competition. During the second quarter and first half of 2019, the stronger U.S. dollar environment, plus significant emerging market devaluations year-over-year in several key markets had approximately 2% currency impact of growth, if we included emerging market pricing. This is essentially driven by large devaluations in three countries, which represent less than 10% of our consolidated Scent in Taste sales.

Turning to business unit performance, in Scent, second quarter currency-neutral sales grew 4% against a solid year ago comp of 5%, with growth in nearly all regions and categories. Performance was strongest in Fragrance Ingredients and Consumer Fragrances both increasing mid single digits. Consumer Fragrances was led by high single-digit growth in Home Care and Fabric Care. Fine Fragrance also was low single digits following a double-digit performance in Q1, led by strong new wins, particularly in EAME. it should be noted that raw material driven price increases represented approximately 4% in the second quarter on a consolidated basis, with the strongest increases in Fragrance Ingredients. In Fragrance Compounds, the composition of growth was balanced, with equal contribution between volume and price.

Scent currency-neutral segment profit increased 19% benefiting from cost and productivity initiatives and more favorable price to input costs. We believe that this was due to the timing of raw materials between the inventory and our P&L, as we continue to see year-over-year increases in our purchases. Raw material costs remain elevated, significantly above historical levels and we will continue to work with our customers on actions to mitigate these increases. In terms of segment profit margin, year-over-year performance was up approximately 200 basis points to 19.2%.

In Taste, second quarter currency-neutral sales decreased approximately 1% against a strong growth of 6% in the year ago period. Growth was strongest in Greater Asia with year-over-year improvements in China, India and the ASEAN region. We also posted growth in EAME led by strong performance in Africa and Middle East. In Latin America and North America, volume erosion with multinational customers was significant and intensified throughout the quarter. When comparing to historical averages, our volume erosion rate in the second quarter was approximately three times our historical average. Taste currency-neutral segment profit was adversely impacted by volume declines, unfavorable price to material costs and a weaker mix, nevertheless segment profit margins will remain best in class among our industry peers.

For Frutarom in the second quarter, sales totaled approximately $382 million. On a stand-alone basis Frutarom sales were flat, driven by the contribution of acquisitions. Excluding the contribution of acquisitions and divested businesses, Frutarom sales decline low single digits were 4%. Similar to what we communicated at our Investor Day, results were primarily driven by declines in F&F ingredients, most notably CitraSource where one of our competitors are no longer purchasing from us, as well as raw material driven price decreases in Natural Colors and weakness in Savory Solutions related to weather conditions in Europe and Canada, and Trade & Marketing where we are deprioritizing.

While all of these are very similar to what we have discussed previously, it is worth noting that Frutarom's Taste volumes decelerated throughout the second quarter driven by weakness in the UK and Ireland. In terms of segment profit, the Frutarom delivered $37 million and $77 million of profit, excluding amortization. The margin profile for Frutarom in the second quarter continues to be strong at a robust 20.1% if you exclude amortization. This has been driven by acquisition related synergies and continued cost discipline.

For the first half of 2019, we have delivered $15 million in integration synergies. As Andreas mentioned earlier, we are now expecting to achieve approximately $40 million in cost synergies in 2019, up from our previous estimate of $30 to $35 million, driven predominantly by procurement optimization. In addition, we continue to deliver on our core productivity program where we drive process improvement simplification and centralization. On a year-to-date basis, we achieved approximately $25 million of core productivity savings in the first half of 2019. Together, we delivered approximately $40 million in year-over-year savings or about 19% expressed in terms of operating profit growth on a combined basis. Operating cash flow in the first half of 2019 was up significantly, from $55 million last year to $185 million this year. Performance was driven by higher earnings in amortization. Core working capital, defined as inventories accounts receivables and accounts payable, improved modestly driven by receivables and payables.

Inventories continue to remain at elevated levels, primarily due to raw material cost increases and safety stocks within the Scent division. We expected inventories will begin to improve in the second half of the year. In the first half, capex as a percentage of sales was approximately 4.6%, driven by new plant and capacity investments mainly in Greater Asia, as well as creative centers and integration-related investments. For the full year we continue to believe the capex or percentage of sales will be between 4.5% to 5%. Bringing all this together, we had a strong $78 million increase in free cash flow in the first half of 2019. A key component of our overall TSR algorithm for our shareholders, it's a competitive and attractive dividend yield. We believe that the 2% threshold is an important one that broadens our potential shareholder base.

Together and today, we are pleased to announce we have authorized a 3% increase in our quarterly dividend, expressing in our confidence to execute on our long-term strategy in our strong financial position. It should be noted that this marks the 10th consecutive year of dividend increases. Considering our year-to-date performance, as well as our outlook for the remainder of the year, we are adjusting our full year sales and adjusted EPS, excluding amortization guidance. For the full year, we now expect to deliver between $5.15 billion and $5.25 billion in sales in 2019, at or approaching the low end of our original guidance of $5.2 million to $5.3 billion. On a combined basis and excluding the impact of currency, growth is expected to be 3% to 5%. The forecast now reflects low versus mid single-digit growth for Frutarom driven by three areas F&F Ingredients, Savory Solutions, and Trade & Marketing. Within F&F ingredients, CitraSource is the primary contributor of the decline as one of our large competitors has significantly reduced its purchases.

We are shifting our focus of this business to make versus buy to drive value creation. In Savory Solutions, performance was impacted by first half weakness, as well as a modestly revised second half outlook related to reductions in volume. We also will deprioritize Trade & Marketing based on our strategic category management approach. From a taste perspective, continued multinational volume erosion in Latin America in North America has lowered our expectation.

It should be noted that we do not expect the second half growth to be stronger than the first half, but Taste performance in the third quarter will be challenged by a strong prior-year comp. We now expect adjusted EPS, excluding amortization to be $6.15 to $6.35, and I will go through the changes in a moment.

On a combined basis and excluding the impact of currency, adjusted EPS , excluding amortization is expected to be 6% to 9%. To provide additional detail related to the adjusted EPS ex-amortization change, I would like to walk you through the drivers. Our original guidance was $6.30 to $6.50. In the second quarter, I highlighted the 10%, $0.10 impact related to the change in top line expectations which is essentially $50 million in sales at low margins, given the impacted businesses, like Trade & Marketing, CitraSource, and PTI.

Mitigating this is the incremental $5 million in integration savings that we announced earlier today. Combining the two, the net operational impact is a reduction of approximately $0.05 to our adjusted EPS, excluding amortization. The larger impact on adjusted EPS, excluding amortization is related to a change in the average effective tax rate on the amortization of intangible assets, as well as a small changes in redeemable non-controlling interests.

The net impact of these combined is approximately $0.10. In the end, our revised guidance for adjusted EPS, excluding amortization is now $6.15 to $6.35. With that, I would like to turn the call back over to Andreas.

Andreas Fibig -- Chairman and Chief Executive Officer

Thank you, Rich. In summary, we believe we have the framework to achieve our long-term ambitions with our Vision 2021 strategy, which is focused on disciplined execution and integration. With that context, we have a long-term commitment to 12% total shareholder return, which is expected to be driven by above 10% EPS growth and a 2% dividend yield.

In the second quarter, we achieved broad-based improvement in sales margin and cash flow. For the full year, we believe we can deliver solid operational results. We are taking action to strengthen the overall growth profile of our business as well as ensuring we capture synergies to generate strong margins on the returns for our shareholders. Expressing our confidence in our long-term strategy and future growth prospects, we also raised our dividend, the 10th yearly consecutive increase. With that, operator, we are now happy to take questions.

Questions and Answers:


[Operator Instructions]. And our first question will come from Mark Astrachan with Stifel. Please go ahead.

Mark Astrachan -- Stifel -- Analyst

Thanks and good morning everybody.

Andreas Fibig -- Chairman and Chief Executive Officer

Good morning.

Mark Astrachan -- Stifel -- Analyst

I guess just on Frutarom and not really sure where to begin. But maybe starting how confident are you there won't be further discoveries at Frutarom related to the alleged bribery negatively impacting sales in other geographies or any sort of things that you can find from an accounting standpoint or anything else? And do you know of or anticipate any U.S. authority to investigate the goings on there at this point?

Andreas Fibig -- Chairman and Chief Executive Officer

Mark, thank you for the question, I take it and given that we have done compliance disclosure here, I will take a moment to reiterate what we have said in our formal disclosure. During the integration of Frutarom, we were made aware of allegations that two Frutarom businesses operating principally in Russia and Ukraine made certain improper payments including to representatives of a number of customers.

So, we promptly commenced investigations. We have a very robust program in place here in particular when we take over companies. So that's, that's very clear. And it's a clear SOP on our side. We have notified relevant U.S. regulatory authorities and relevant Israeli regulatory authorities. So I think that's good and done. We have not uncovered any evidence suggesting the payments had any connection to the U.S. based on the information we have. We believe that these improper payments are no longer being made. The estimated affected sales represents less than 1% of combined pro forma net sales for 2018.

So, we do not believe the impact from these matters is a worry material to our results of operations or financial conditions. I believe that's a super important point as well. We have taken or will take appropriate remedial actions with respect to the matters I have described. And I want to assure you that we have committed to the highest standards of ethics and compliance and have strict compliance policies in place. Also investigations are continuing based on the results to date, and other compliance related integration activities, we are not currently aware of similar instances of misconduct in any other geographies.

So, I would say all in all, we stick to what we have said in our disclosure. We feel very comfortable that we have a good handle on it. And I'm actually very proud about the program we are running here and how all the teams are working together to get these things and we've done in the appropriate manner.

Mark Astrachan -- Stifel -- Analyst

Okay, just staying with Frutarom, I guess your organic sales decline was much worse than was expected. I think, including your own expectations. So what gives confidence you can get back the growth in the second half of the year, [Indecipherable] comparison and what is the reasonable long-term growth rate for the business going forward?

And I just wanted to follow up on the first question, just. So how confident are you there is not going to be another stone unturned that find something else that you're not anticipating at this point, I mean how has thorough has the investigation been by the Board and the committees?

Andreas Fibig -- Chairman and Chief Executive Officer

Sure. I think more, that's a fair question on principally despite that any investigation, nothing has changed since our Investor Day, because we feel very good about our strategy. We see also that the portfolio of the acquisition is helping us in terms of getting exposure to some of the higher-growth areas like the health ingredients or the natural food protection which was even shown in the second quarter or the inclusion business as well.

So portfolio wise, we are very happy. What we do certainly is that we prioritize our portfolio. As we said, we are trying to maximize returns and we are de-emphasizing the marketing and trade business for example because there's not a lot of profitability in and that obviously shows. We are very, let's say, clear and happy about the customer portfolio. We haven't lost too many customers here and I think still we believe that some of the small and mid-size customers have good growth rates, and that will help us with the business.

The portfolio, it is proving toward naturals, and that's a trend, which is not not changing through that event. Talking about the integration, I believe what is important to see here is that in general despite the the compliance topic we just talked about, we are very happy with what is happening during the integration, because you see it on the cost synergies, everything in terms of integration, whether that's North America, Latin America or Asia or Europe is working as planned. We see that we get more cost synergies and Rich just mentioned that in his presentation, how then we even start and that's predominantly driven by procurement which is good news because, first of all, it has no impact on our employees and no impact on our customers as well. So that's an important one. On the sales side, certainly the second quarter was softer than I would like to have it, but we will see that this will turnaround in the second half, as we said during the Investor Day as well . And we believe a mid single-digit growth rate for the business is very doable, in particular if we emphasize the strong parts in the high growth parts of the portfolio. Having said this, we have now a real good team in place for the cross-selling synergies. You will hear more about this over the next couple of calls. We haven't seen too much of a result, Rich just mentioned the $8 million but there's certainly more to come, and actually very exciting opportunities for us to cross-sell the portfolios to the different customer groups on both sides of the business.

Having said this, I would like to to mention as well that we have seen now a nice turnaround on the Scent business side that has not too much to do with Frutarom just a small, a part of it, but we see that we are turning around despite the crisis we had with raw materials in the last year. Nicolas's business is going in the right direction growth-wise as as well. So, we are very optimistic on this front as well, as you know there was a bit of a pickup in the last year as well and the turnaround, this is pretty strong year. So that's how I would, let's say characterize where we stand in terms of the Frutarom business, but making the remark on the total portfolio as well.

Richard O'Leary -- Executive Vice President and Chief Financial Officer

Andreas, maybe just, Mark, a couple of quick comments on my part, I mean I'll reiterate what Andreas said, I think we feel strongly about the ability that Frutarom business to grow mid-single digits in the medium to long term. I think we're still going to some of the challenges that we've seen for the last three quarters like CitraSource and Trade & Marketing and the Savory business are not going to correct overnight. I think we would expect to see low single-digit growth for Frutarom ex M&A in the second half of this year. But we're not going to get I think that doesn't change our long-term perspectives in terms of the potential of the business.

Michael DeVeau -- Head of Investor Relations and Communications

What we see and I might add this, but it's more mid to long-term markets. On the R&D technologies, we are very, we are very optimistic what that can deliver for us going forward. But you know that takes a bit of more time to realize. Okay?


Our next question will come from Mike Sison with KeyBanc. Please go ahead.

Michael Sison -- KeyBanc -- Analyst

Hey, guys. I guess...

Michael DeVeau -- Head of Investor Relations and Communications

Hi, good morning.

Michael Sison -- KeyBanc -- Analyst

Good morning. Two quick ones. I think in the you're compliance commentary mentioned that there were some senior management at Frutarom involved. Are they still around? How have you sort of changed that dynamic culturally? And then as a quick follow-up, what are you looking for for Frutarom in the second half of the year in terms of either constant currency growth, it was down 4% you mentioned in 2Q, and maybe just kind of thoughts on profitability, I think you said, operating margins, ex amortization, was still pretty healthy, do you expect it to stay at that levels in the second half of the year? Thank you.

Andreas Fibig -- Chairman and Chief Executive Officer

Okay. Let me, let me take the compliance piece for us we have taken remedial actions on the involved people. The good thing is, it is very contained to geographically, so that makes it easier for us to act on that. Culturally, we have started with actually day one and all of our town hall meetings in the new company as we usually do when we take over companies that we educate people on the compliance code, on the code of conduct, everybody is going through the training, whether it's a live training or training via one of their computers. So we feel good about this and this is coming actually nicely, nicely together. This is an unfortunate event, but as I said it's geographically very, very limited. And then I hand over to Rich on the margin question.

Richard O'Leary -- Executive Vice President and Chief Financial Officer

Yeah. So my two things. One, on your question on the second half. I just want to clarify what the answer I gave to Mark. Frutarom on the second half of the year, I think it's low single-digits on a two-year average basis. Given the weak Q3 last year for Fruit, it will be stronger Q3 versus Q4. In terms of margins, I think we had a very strong quarter Q2 despite the challenges from a topline standpoint. You heard the comments I made regarding the very strong quarter in margin performance for Scent. I think some of that as I said in my comments were timing, and so I don't expect that. I think this in Q3 and Q4 will be a bit more pressured on the Scent side in terms of margins with input costs remaining elevated. The team has done a very good job in terms of mitigating that impact, related to the price realization. But there is timing in terms of inventory when the raw materials flow through the P&L. So, and then when you get to Q4 obviously that season, there is a bit of seasonality where our margin profiles in Q4 are generally the weakest of over the full year. So, I would expect the second half to be modestly below where we were in the first half of this year.


Our next question will come from Adam Samuelson with Goldman Sachs. Please go ahead.

Adam Samuelson -- Goldman Sachs -- Analyst

Yes, thanks, good morning everyone.

Andreas Fibig -- Chairman and Chief Executive Officer

Good morning, Adam.

Adam Samuelson -- Goldman Sachs -- Analyst

So, first just on the compliance question. Can you tell how long were the alleged payments actually happening? And specifically you've cited in the last couple of quarters some sales declines in the Savory business in Frutarom in Eastern Europe. Is there any or nexus or common customer overlap between those, just want to be clear on that point? And then secondly on the Taste business, maybe just a little bit more color on the volume declines that you're seeing in the Americas in the second quarter and the first half of the year, they seem to be a bit shocker than what we would see from the food and beverage company, so just a little bit more color perhaps by category or kind of where you're seeing the greatest pressures? Thank you.

Richard O'Leary -- Executive Vice President and Chief Financial Officer

So, let me start with the last one in terms of the volume side of it. It's, as I said in the comments, and I think Andreas said also. I mean what we're seeing in the Taste side is significant volume erosion on existing business. Again, if you look at, when we look at our fundamentals, we don't believe we're losing share. When you look at us on the pricing, adjusted fine growth or total topline growth in on a two-year basis for the first half of the year, we're very much in line with competition. So, we are confident that we're not losing share. We are seeing significant volume erosion on existing business. Our win rates remain good for both businesses, pretty much add five year average. So we're not seeing any erosion in the business. We've talked about in the past that we see significant upside going forward on the Scent business in terms of access to new business. So, we believe it's very much a volume erosion piece where Q3, Q2 was much worse than what we saw in Q1. It's one of those things that I've seen these trends occur over time and it's hard to predict when those things sort of return to the norm. And it can be very from their underlying product mix and the categories where we operate with a particular customer, their supply chain. So, it's hard to predict, but I don't see this as being a long-term trend. As I said in my comments related to the Frutarom Taste, it was primarily an issue in Europe. Again, it was quite strong with mid to low single-digit growth in the EAME Taste business for Frutarom through the end of May, and then it was a very disappointing and challenging June, which drove the declines that was a bit unexpected from where we thought we were going to be. From the compliance standpoint, based on what we've seen for the investigation, they may have been occurring for a few years, but there's never been indication that they're going to material now any particular year.

Andreas Fibig -- Chairman and Chief Executive Officer

Maybe I add to the first point, which made, if I look at our Taste business, we had in particular in '18 very, very strong growth in the first and the second quarter, 6% each. So it's strong comparables, and we can say that in the third quarter, we have to had to slightly better start into the third quarter for the Taste and for the food options. I think that's important.

Richard O'Leary -- Executive Vice President and Chief Financial Officer

Yeah. And the last question which I forgot Adam was in terms of customer overlap, it's pretty negligible customer overlap, particularly in this business.


Our next question will come from Heidi Vesterinen with Exane BNP Paribas. Please go ahead.

Heidi Vesterinen -- Exane BNP Paribas -- Analyst

Hi, good afternoon. So, if we stick back and think about your performance over the past year, as we've seen that you've tended to underperform on your topline targets in once here -- once again this year despite help from a [Indecipherable] and strong pricing in response to exceptional inflation, you're still below targets in terms of organic growth. So can you help us understand what you're doing internally both on the legacy IFF side and the Frutarom side to get back on track? Do you think maybe some more radical changes might be needed may be in terms of investment or personnel or so on to ensure that you can get back to your long-term targets? Thank you.

Andreas Fibig -- Chairman and Chief Executive Officer

So Heidi, that's a good, it's a good point, because I would say all the other parameters and KPI's are going actually pretty, pretty well and we focus a lot on the top line growth. And for me or actually for us as a management team, the recipe is very, very clear. What we need is we have to focus our activities on the most driving parts of the portfolio, where we have now a much better portfolio than we had before.

So we have a couple of let's say areas which might be small at the moment, but sure from the market perspective, really nice, nice growth for us. Like the inclusions like the health ingredients and natural food or even the active cosmetics. So we believe that's the first one. The second thing is, where we have to look in, is in our customer structure. And here we have to drive it's true and particularly on the Taste side with some of the smaller and mid-sized customers. We are certainly the acquisition helps a lot. We take the blueprint we have from all our Tastepoint. We will drive it through. We have now integrated the Frutarom Taste business into Tastepoint already in the U.S., and actually in that regard, if I can give the detail we have a double-digit growth on this side.

It's a very nice, nice growth of the business. So we like that a lot. The next thing is on the Scent side, because I don't want to short change it too much, but we have no access to more of our core list of our most important customers. And I know that there are lot of activities ongoing and you know, these are all big customers. It takes, let's say, 9 to 12 to 15 months to really capitalize on it, but we see strong interest. We see strong first let's say wins on our side and that will help us to, let's say, accelerate the top line side, on the Scent business as well.

On top of it and that's what's in the works and we will report on this is the cross-selling aspect. We have now moved the leader of our key account bigger key account from the Taste business into the role of being the head of cross-selling and total solutions business. He is building a small but very let's say powerful and nimble organization to facilitate the cross-selling between the two organizations, and we believe that can deliver very nicely on our top line growth.

So if I add this altogether, I think we come, we can come back to the good growth rate we have, we have outlined to 5% to 7%. We believe it's very, very doable. And the first thing, the first, let's say, initial let's say science we see going in the direction.


Our next question will come from John Roberts with UBS. Please go ahead.

John Roberts -- UBS -- Analyst

Thank you, I just wanted to put some numbers to what's going on in the Taste with the 3x erosion. So is it like normally you see 10% to 15% products discontinued in any given year by Taste customers and normally they replace that, but now you're seeing something like 30% to 45% kind of discontinue to older products and even though you're having the new wins, they are not launching the new products at an offsetting rate here. Is that the dynamic that we're talking about ?

Richard O'Leary -- Executive Vice President and Chief Financial Officer

John putting in perspective, I mean on a 5-year trend, volume on existing business is slightly negative. So call it low single-digit down 1%. For the last, and now at the current rates, particularly in Q2, we're in a mid-single digit range. So that's by far the single biggest driver. I mean as I said earlier, our win rates are in line with long-term 5-year trends. Pricing is slightly positive, a little bit below the 5-year average but part of that's been driven by what we've seen over the last three years with Vanilla. So I would not say it's fundamentally it's all the volume erosion on existing business. Some of it may be driven by shorter cycle times, but that's the fundamental driver in terms of the biggest change in the last two quarters.


Our next question will come from Alexandra Thrum with Morgan Stanley. Please go ahead.

Alexandra Thrum -- Morgan Stanley -- Analyst

Hi, thanks for taking my question. Just a quick one on margins in both the Scent and Taste division. You've sort of explained what's happening in the top line dynamics. But when I look at Taste, could you break up, how much of that margin decline is driven by volume versus also the pricing versus raws and then on the flip side you've margins have obviously expanded quite decently I expect because mainly because of pricing in Scent, but could you please break down that margin expansion both between pricing versus raws and volume?

Richard O'Leary -- Executive Vice President and Chief Financial Officer

Sure, Alexandra, I mean in terms of Taste, I mean the pricing impact was pretty negligible I think the biggest driver for Taste is on the input costs. In terms of, it's more of a mix issue I mean I think our overall view in terms of mix of consumption as opposed to the mix of product, I think that's a smaller impact from a mix standpoint. But as similar to what we've seen on the Taste side, as we consume individual lots or product-by-product, we can have some fluctuation out. So the biggest driver into the margin pressures in Taste is one the input costs, and two is the lower volumes is hurting us from an absorption standpoint.

When it -- from a taste standpoint you heard in the comments that pricing is a bigger driver from a Taste standpoint, certainly on the -- our Scent standpoint, certainly on the Ingredient side, but also in the compounds. As I said earlier in my comments, the teams have done a very good job of aggressively pursuing price realization to offset that. And I said earlier, we had I would call a unique situation in Q2 where we had mix of consumption of raw materials, which drove a favorable margin progression in Q2, which I don't expect to repeat in the second half of this year for Scent. So that's why I said earlier, I would expect margin profiles in Scent to come down from where they were in Q2, given the mix of raw materials.

We still are seeing elevated prices from Scent. They are at near all time highs. I think we've seen that the rate of increase has slowed. So I think that's starting to be a positive trend, but we don't expect to see any relief in the near term from a input cost standpoint.


Our next question will come from Jeff Zekauskas with JPMorgan. Please go ahead.

Jeffrey Zekauskas -- JPMorgan -- Analyst

Thanks. Thanks very much. Can you talk about the change in global expenses from the first quarter to the second? I think you went from about $19 million to $13 million, and then to go back to the $13 million sequential decrease in cost of goods sold, I would think maybe $3 million is from volume and maybe there is $2 million or $3 million from the Frutarom. But I take it there is some hedging gains in there. And can you describe what went on from a raw material standpoint a little bit more precisely, if you don't mind?

Richard O'Leary -- Executive Vice President and Chief Financial Officer

Sure, Jeff. So from a corporate expense standpoint, the single biggest driver is the cash flow hedging as you said. It's about a $5 million impact, and so that's the biggest driver. And as you said, it also impacts COGS. I think clearly the volume impact is a further reason in terms of $13 million impact.

I think the other thing that keep in mind as I said earlier, we did have, I'm going to call it a mix impact in terms of the Scent, in terms of the raw material consumption, as it flow-through from finished goods and finished goods and raw materials into COGS. So there is a timing impact there. I think those are the biggest drivers. In terms of the sequential performance from an overall perspective, we still expect to see mid-single digit inflation from a raw material standpoint for the full year or that's in line with what we've seen our expectations from the beginning of the year. And as I said, just a moment ago, I think we are seeing starting to see some slowdown in terms of the rate of the increase, but we're still at very elevated levels.


We'll take our next question from Brett Hundley with Seaport Global. Please go ahead.

Brett Hundley -- Seaport Global -- Analyst

Hey, thank you. Good morning, guys. I mean, Rich -- I just have one detailish type question for you. So, if I go to the change in EPS guide for the year, I wanted to focus in on the change in non-controlling interest piece and just ask you whether, is that related to like the carrying value of those fruits subs dropping below the redemption value? Is it due to a change over to consolidated status away from non-consolidated status, because I will admit your other income line in Q2 was less of a benefit than I thought it would be relative to Q1?

So sorry for the detailish type question but just wanted to understand that better.

Richard O'Leary -- Executive Vice President and Chief Financial Officer

No, look, I mean, I think so out of that $0.10, I'd say probably $0.06 to $0.07 of that is the change in the effect, average effective tax rate on the amortization. So that one is clear. On the non-controlling interest, it's really a mark-to-market adjustment that we have to monitor and adjust each quarter based on the results and the outlook for the individual entities in which the minority interest, there is a redeemable component of the minority interest. So it's basically, it is based on the underlying performance, and the projections for those businesses. And so there has been a slight change between where we are at the beginning of the year and based on the latest projections.


And there are no further questions at this time. So I will turn it back to Andreas for closing remarks.

Andreas Fibig -- Chairman and Chief Executive Officer

Yeah. Thank you very much for participating. I think it was an important call with a couple of really important messages we wanted to make, and we are now basically happy to take all the one-on-ones we wanted to do and to give you more, more explanation around some of the outcome of the businesses. So thank you very much, and talk to you soon. Thank you.


[Operator Closing Remarks]

Duration: 59 minutes

Call participants:

Michael DeVeau -- Head of Investor Relations and Communications

Andreas Fibig -- Chairman and Chief Executive Officer

Richard O'Leary -- Executive Vice President and Chief Financial Officer

Mark Astrachan -- Stifel -- Analyst

Michael Sison -- KeyBanc -- Analyst

Adam Samuelson -- Goldman Sachs -- Analyst

Heidi Vesterinen -- Exane BNP Paribas -- Analyst

John Roberts -- UBS -- Analyst

Alexandra Thrum -- Morgan Stanley -- Analyst

Jeffrey Zekauskas -- JPMorgan -- Analyst

Brett Hundley -- Seaport Global -- Analyst

More IFF analysis

All earnings call transcripts

AlphaStreet Logo

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

Motley Fool Transcribers has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

International Flavors & Fragrances Inc. Stock Quote
International Flavors & Fragrances Inc.
$94.00 (-2.37%) $-2.28

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.